New Zealand has agreed to procure 60,000 doses of Pfizer's COVID-19 oral antiviral candidate, PF-07321332, subject to approval by the country's regulator.
New Zealand secures 60,000 doses of Pfizer's COVID-19 treatment
December 6, 2021 Latest NewsBioPharmaLatest Video
New Stories
-
Stakeholders force Pharmac backdown on move to scrap childhood cancer access program
March 19, 2024 - - Latest News -
ViiV Healthcare Australia announces recipients of 2023 Positive Action Community Grants
March 19, 2024 - - Latest News -
'I'm a big believer that we as public servants need to engage honestly with our stakeholders'
March 19, 2024 - - Latest News -
A misguided response disconnected from its own history and reality
March 18, 2024 - - Latest News -
Where are the stewards to maintain and protect this critical public health program?
March 18, 2024 - - Latest News -
The fast-finishing AstraZeneca secures Pharma Cup for 2024 Kosi Challenge
March 18, 2024 - - Latest News -
Merck expands fertility benefit for its employees in Australia
March 15, 2024 - - Latest News